The meeting aimed to create better engagement with key industry & academic leaders and establish a platform where the challenges of Industry and how academic/research institutions can forge new R&D partnerships and alliances can be discussed. One of the event’s goal was to boost the discovery of new drugs and push towards healthcare innovation and the formation of new start-ups.
Graeme Bilbe, R&D Director, DNDi and Suman Rijal, Director of DNDi Regional Office India took part in the event.
Session
Opportunities & Challenges in Anti-Microbial Drug Discovery
Date: Thursday, October 5, 2017
| Innovative drugs for neglected patients |
| Panel Discussion
|
More information:
